Plenty of price catalysts as per latest presentation, plenty of...

Plenty of price catalysts as per latest presentation, plenty of value add to come IMO.

Ongoing data and results from the existing extended clinical trial, that for me is confirmation NTI's strain is very valuable to parents and patients alike. Happy to support such a life changing treatment for paediatric patients as there is little support in the current climate. Sure there are treatments but with those treatments comes pretty harsh side effects.

Multiple pathways can be taken by the company here IMO

Let's allow the experienced board to steer the ship, I have full confidence in what NTI are offering, they're in a league of their own.

Have been here since the 3 cent days, my conviction has grown, believers carry stocks higher, hopefully these new holders are exactly that believers.



AIMO of course DYOR